Antitumoral Activity Of Nitric Oxide-Releasing Compounds
Background: Despite significant improvements in the conventional anti-ovarian cancer therapies, tumor cell resistance to various cytostatic drugs remains a relevant problem. Therefore, the new cancer treatment strategies are being developed. Among many agents that have been studied for their potenti...
Main Authors: | Magdalena Klink, Michal Kielbik, Izabela Szulc Kielbik, Patrycja Przygodzka, Zofia Sulowska |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-08-01
|
Series: | Redox Biology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213231715001421 |
Similar Items
-
Mycobacterium tuberculosis Requires Cholesterol Oxidase to Disrupt TLR2 Signalling in Human Macrophages
by: Izabela Szulc-Kielbik, et al.
Published: (2019-01-01) -
Impact of Selected Signaling Proteins on SNAIL 1 and SNAIL 2 Expression in Ovarian Cancer Cell Lines in Relation to Cells’ Cisplatin Resistance and EMT Markers Level
by: Michal Kielbik, et al.
Published: (2021-01-01) -
Calreticulin—Multifunctional Chaperone in Immunogenic Cell Death: Potential Significance as a Prognostic Biomarker in Ovarian Cancer Patients
by: Michal Kielbik, et al.
Published: (2021-01-01) -
The Potential Role of iNOS in Ovarian Cancer Progression and Chemoresistance
by: Michal Kielbik, et al.
Published: (2019-04-01) -
Cholesterol oxidase is indispensable in the pathogenesis of Mycobacterium tuberculosis.
by: Magdalena Klink, et al.
Published: (2013-01-01)